People who are currently using Raptiva or other biologics, for treatment of chronic moderate to severe plaque psoriasis may be eligible to participate in a 5 year observational study looking at the long term safety of Raptiva.

Participation in this research study may include the following at no cost:

• Study visits to the University of Iowa Department of Dermatology clinic and study phone calls every six months for 5 years
• Study-related laboratory tests and examinations

Compensation is provided.

For more information or to consider participation please contact:

Clinical Research Coordinator at (319) 353-6439